Prospective antibacterial inhibition of c-type cytochrome synthesis

Varela, 2021, Bacterial resistance to antimicrobial agents, Antibiotics, 10, 593, 10.3390/antibiotics10050593 Sutherland, 2021, In vitro reconstitution reveals major differences between human and bacterial cytochrome c synthases, eLife, 10, 10.7554/eLife.64891 Pérez-Mejías, 2019, Cytochrome c: surfing off of the mitochondrial membrane on the tops of complexes III and IV, Comput. Struct. Biotechnol. J., 17, 654, 10.1016/j.csbj.2019.05.002 Zou, 1997, Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3, Cell, 90, 405, 10.1016/S0092-8674(00)80501-2 Frawley, 2009, CcsBA is a cytochrome c synthetase that also functions in heme transport, Proc. Natl. Acad. Sci. U. S. A., 106, 10201, 10.1073/pnas.0903132106 Rončević, 2019, Antimicrobial peptides as anti-infective agents in pre-post-antibiotic era?, Int. J. Mol. Sci., 20, 5713, 10.3390/ijms20225713 Iyisan, 2019, Modular approach for the design of smart polymeric nanocapsules, Macromol. Rapid Commun., 40, 10.1002/marc.201800577 Pethe, 2013, Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis, Nat. Med., 19, 1157, 10.1038/nm.3262 Lu, 2018, The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd, Sci. Rep., 8, 265 Rajagopal, 2013, The hydrogen-peroxide-induced radical behaviour in human cytochrome c-phospholipid complexes: implications for the enhanced pro-apoptotic activity of the G41S mutant, Biochem. J., 456, 441, 10.1042/BJ20130758